Creating content about the COVID-19 vaccines requires a deliberate, well-executed plan. As you begin developing vaccine content at your institution, use our step-by-step checklist to ensure a smooth rollout.
The COVID-19 pandemic has changed virtually every aspect of life around the world. Restrictions on movement and gatherings are impacting access to contraceptives and health care. Community health workers and providers, who are key linkages to service provision in many contexts, are also limited in their movements.
Behavioral design checklists can help a one discover in minutes if a program, product or service is designed for how people really behave—and find proven tactics for improvement. It is suggested that these checklists be utilized to ensure that programs are optimized for success.
This checklist ensures that those developing COVID-19 messages will keep in mind certain guidelines.
This checklist was developed on February 27, 2020 by the OFDA-funded READY Initiative for Outbreak Preparedness Planning Workshops conducted at regional and country
levels. It is iterative and will be updated to reflect updates in Covid-19 guidance.
This checklist was developed on February 27, 2020 by the OFDA-funded READY Initiative for Outbreak Preparedness Planning Workshops conducted at regional and country levels. It is
iterative and will be updated to reflect updates in Covid-19 guidance.
The OFDA-funded READY Initiative developed this checklist for INGOs/NGOs working in humanitarian response, primary to use in regional/country level Outbreak Preparedness
This is a Social and Behavior Change program monitoring checklist prepared by the Nepali provincial Operational Management team. This team is part of the project "Social and Behavior Change Capacity Strengthening Support Material for the Local Level."
Breakthrough ACTION developed the Essential Elements for Costed Implementation Plans: Social and Behavior Change Checklist to support governments, donors, and implementing partners to ensure best practices in SBC are strategically integrated into—and appropriately budgeted for—in their family planning (FP) Costed Implementation Plans (CIPs).
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial was launched in 2015 to test the comparative risk of HIV acquisition among women using one of the following three contraceptive methods: depo-medroxyprogesterone acetate intramuscular (DMPA-IM), also known as Depo-Provera, two-rod levonorgestrel sub-dermal implant (LNG-Implant), branded as Jadelle, and the copper intrauterine device (Copper-IUD).